SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (13335)10/6/2004 11:14:13 AM
From: Michael Young  Respond to of 52153
 
The libility figures are going to be staggering. I spoke with a plaintiff lawyer the other day who handles drug liability cases. He believes these cases are going to be very, very difficult for Merck to defend. The pool of cases is very large, the liability evidence is strong, and the damages per plaintiff are substantial.



To: tom pope who wrote (13335)10/6/2004 9:08:55 PM
From: NOW  Respond to of 52153
 
And NOT JUST VIOXX; hohoho
abcnews.go.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News